May 17, 2012 (San Diego, California) — A 1-year randomized study of postmenopausal women who took the new oral selective estrogen-receptor modulator (SERM) ospemifene (Ophena, Shionogi) for ...
If a woman is being treated with topical estrogen for atrophic vaginitis, does she need to use a progestin (synthetic progesterone) to protect the uterus? The best clinical practice at this point in ...
Any bleeding after menopause is abnormal, and a doctor should always check it. Vaginal atrophy is the most common cause of ...
(a) The tumor shows focal glandular architecture along with solid areas (100×, H&E). (b, c) The solid component exhibits prominent lymphocytic infiltrate with tumor heterogeneity (100×, H&E). (d) The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback